• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


ANP Change in substantial holding from AEF01/04/20 download Created with Sketch. 205.38KB
ANP Phase II DMD trial database lock and final results on track18/03/20 download Created with Sketch. 169KB
ANP ATL1102 Phase II data to be presented at DMD Conference05/03/20 download Created with Sketch. 189.03KB
ANP Half Yearly Report and Half Year AccountsPRICE SENSITIVE28/02/20 download Created with Sketch. 2.4MB
ANP Appointment of US-based Consultant Medical DirectorPRICE SENSITIVE27/02/20 download Created with Sketch. 141.79KB
ANP Results in DMD unlock value creation potential of ATL1102PRICE SENSITIVE06/02/20 download Created with Sketch. 109.86KB
ANP Quarterly Update & Appendix 4CPRICE SENSITIVE30/01/20 download Created with Sketch. 261.9KB
ANP ANP Presentation for SACHS 3rd Neuroscience Innovation Forum13/01/20 download Created with Sketch. 2.44MB
ANP ANP to Present at Neuroscience Innovation Forum in the US10/01/20 download Created with Sketch. 200.78KB
ANP Antisense Therapeutics Limited - Listed Options raise $5.5MPRICE SENSITIVE03/01/20 download Created with Sketch. 152.36KB
ANP Appendix 3B and 708A notice03/01/20 download Created with Sketch. 565.3KB
ANP Change of Director's Interest Notice (RM, MD, GM, GP, WG)24/12/19 download Created with Sketch. 335.74KB
ANP Appendix 3B23/12/19 download Created with Sketch. 334.26KB
ANP Change in substantial holding23/12/19 download Created with Sketch. 202.39KB
ANP Change in substantial holding from AEF20/12/19 download Created with Sketch. 564.91KB
ANP Change of Director's Interest Notice - WG20/12/19 download Created with Sketch. 237.52KB
ANP Change of Director's Interest Notice - RM20/12/19 download Created with Sketch. 215.4KB
ANP Appendix 3B19/12/19 download Created with Sketch. 331.4KB
ANP Change of Director's Interest Notice (RM)19/12/19 download Created with Sketch. 216.49KB
ANP Change of Director's Interest Notice (MD)18/12/19 download Created with Sketch. 217.32KB
ANP Change of Director's Interest Notice (GM)18/12/19 download Created with Sketch. 218.46KB
ANP Appendix 3B18/12/19 download Created with Sketch. 331KB
ANP Reinstatement to Official QuotationPRICE SENSITIVE17/12/19 download Created with Sketch. 214.01KB
ANP Positive results reaffirm plans to advance ATL1102 to P2bPRICE SENSITIVE17/12/19 download Created with Sketch. 318.57KB
ANP Antisense Therapeutics - Underwriting of Listed OptionsPRICE SENSITIVE17/12/19 download Created with Sketch. 122.56KB
ANP Change of Director's Interest Notice - RM16/12/19 download Created with Sketch. 279.65KB
ANP Appendix 3B16/12/19 download Created with Sketch. 330.53KB
ANP Suspension from Official QuotationPRICE SENSITIVE16/12/19 download Created with Sketch. 433.54KB
ANP Clarification of the Trading Halt12/12/19 download Created with Sketch. 70.84KB
ANP Trading HaltPRICE SENSITIVE12/12/19 download Created with Sketch. 432.15KB
ANP Results of Meeting11/12/19 download Created with Sketch. 267.87KB
ANP AGM Presentation 2019PRICE SENSITIVE11/12/19 download Created with Sketch. 2.28MB
ANP Change of Director's Interest Notice - Robert Moses04/12/19 download Created with Sketch. 269.78KB
ANP Appendix 3B04/12/19 download Created with Sketch. 257.7KB
ANP Appendix 3B25/11/19 download Created with Sketch. 301.94KB
ANP Dosing completed in ATL1102 Phase II DMD trialPRICE SENSITIVE20/11/19 download Created with Sketch. 146.68KB
ANP Additional ATL1102 trial data presented at DMD UK conference18/11/19 download Created with Sketch. 1.86MB
ANP Expiry of Listed Options15/11/19 download Created with Sketch. 150.38KB
ANP Change in substantial holding from AEF14/11/19 download Created with Sketch. 83.11KB
ANP Antisense Therapeutics Listed Option ANPOB Exercise13/11/19 download Created with Sketch. 93.8KB
ANP Appendix 3B12/11/19 download Created with Sketch. 256.97KB
ANP Notice of Annual General Meeting/Proxy Form11/11/19 download Created with Sketch. 9.7MB
ANP Change in substantial holding from AEF06/11/19 download Created with Sketch. 83.09KB
ANP Appendix 4G31/10/19 download Created with Sketch. 205.43KB
ANP Annual Report31/10/19 download Created with Sketch. 8.51MB
ANP Appendix 3B29/10/19 download Created with Sketch. 257.21KB
ANP Neuromuscular Drug Development Summit Poster Presentation25/10/19 download Created with Sketch. 511.71KB
ANP Appendix 4C - quarterlyPRICE SENSITIVE25/10/19 download Created with Sketch. 290.03KB
ANP Techknow Conference Presentation22/10/19 download Created with Sketch. 2.34MB
ANP ANP to present at Neuromuscular Drug Development Summit USA17/10/19 download Created with Sketch. 183.52KB
ANP Change in substantial holding11/10/19 download Created with Sketch. 252.14KB
ANP Change in substantial holding from AEF09/10/19 download Created with Sketch. 81.87KB
ANP Response to ASX Price QueryPRICE SENSITIVE07/10/19 download Created with Sketch. 479.4KB
ANP Appendix 3B04/10/19 download Created with Sketch. 306.63KB
ANP Positive preliminary results from ATL1102 DMD Phase II trialPRICE SENSITIVE18/09/19 download Created with Sketch. 461.75KB
ANP Trading HaltPRICE SENSITIVE17/09/19 download Created with Sketch. 430.81KB
ANP ATL1102 for DMD European regulatory interactionsPRICE SENSITIVE02/09/19 download Created with Sketch. 161.6KB
ANP Appendix 4E and Full Year Statutory AccountsPRICE SENSITIVE30/08/19 download Created with Sketch. 911.49KB
ANP Acromegaly Early Access Program Status UpdatePRICE SENSITIVE26/08/19 download Created with Sketch. 150.58KB
ANP Change in substantial holding31/07/19 download Created with Sketch. 260.61KB
ANP Phase II DMD clinical trial on track for dosing completionPRICE SENSITIVE24/07/19 download Created with Sketch. 104.3KB
ANP Appendix 4C - quarterlyPRICE SENSITIVE18/07/19 download Created with Sketch. 203.32KB
ANP Conference Presentation25/06/19 download Created with Sketch. 2.72MB
ANP Updated Investor Presentation29/05/19 download Created with Sketch. 2.6MB
ANP Phase II clinical trial in DMD Fully EnrolledPRICE SENSITIVE24/05/19 download Created with Sketch. 135.89KB
ANP Employee Share Ownership Plan (ESOP)26/04/19 download Created with Sketch. 63.51KB
ANP Appendix 4C - quarterlyPRICE SENSITIVE26/04/19 download Created with Sketch. 247.86KB
ANP Phase II clinical trial in DMD UpdatePRICE SENSITIVE04/04/19 download Created with Sketch. 158.07KB
ANP Change in substantial holding18/03/19 download Created with Sketch. 215.44KB
ANP Change in substantial holding from AEF18/03/19 download Created with Sketch. 300.87KB
ANP Becoming a substantial holder CityCastle Pty Ltd15/03/19 download Created with Sketch. 799.76KB
ANP Completion of $1,600,000 Share Placement15/03/19 download Created with Sketch. 353.7KB
ANP Placement to Accelerate Development of ATL1102 in DMDPRICE SENSITIVE13/03/19 download Created with Sketch. 106.85KB
ANP Trading HaltPRICE SENSITIVE11/03/19 download Created with Sketch. 631.05KB
ANP Pause in tradingPRICE SENSITIVE11/03/19 download Created with Sketch. 116.97KB
ANP Half Yearly Report and AccountsPRICE SENSITIVE27/02/19 download Created with Sketch. 563.62KB
ANP Appendix 4C - quarterlyPRICE SENSITIVE30/01/19 download Created with Sketch. 204.38KB
ANP Updated Company Presentation23/01/19 download Created with Sketch. 3.77MB
ANP Phase II clinical trial in DMD UpdatePRICE SENSITIVE18/01/19 download Created with Sketch. 131.34KB
ANP Receipt of R&D Tax Incentive paymentPRICE SENSITIVE04/12/18 download Created with Sketch. 87.74KB
ANP Results of Meeting29/11/18 download Created with Sketch. 174.94KB
ANP AGM Presentation29/11/18 download Created with Sketch. 1.6MB
ANP Appendix 4G09/11/18 download Created with Sketch. 180.06KB
ANP Change of Director's Interest Notice (RM)02/11/18 download Created with Sketch. 133.82KB
ANP Change of Director's Interest Notice (MD)02/11/18 download Created with Sketch. 133.63KB
ANP Investor Presentation30/10/18 download Created with Sketch. 1.68MB
ANP Notice of Annual General Meeting/Proxy Form29/10/18 download Created with Sketch. 4.2MB
ANP Appendix 4C - quarterlyPRICE SENSITIVE29/10/18 download Created with Sketch. 187.13KB
ANP Response to ASX Price and Volume QueryPRICE SENSITIVE16/10/18 download Created with Sketch. 164.63KB
ANP Duchenne ACTT Now Conference 201806/09/18 download Created with Sketch. 116.61KB
ANP Full Year Statutory AccountsPRICE SENSITIVE29/08/18 download Created with Sketch. 1.04MB
ANP First Patient Dosed in Phase II DMD Clinical TrialPRICE SENSITIVE29/08/18 download Created with Sketch. 121.94KB
ANP Pause in TradingPRICE SENSITIVE29/08/18 download Created with Sketch. 117.63KB
ANP ANP to Present at 14th Annual Bioshares Biotech Summit27/07/18 download Created with Sketch. 1013.55KB
ANP Change of Director's Interest Notice (RM)26/07/18 download Created with Sketch. 20.77KB
ANP Appendix 4C - quarterlyPRICE SENSITIVE24/07/18 download Created with Sketch. 529.19KB
ANP Company Appointment23/07/18 download Created with Sketch. 115.02KB
ANP ANP initiates ATL1102 Phase II clinical trial in DMDPRICE SENSITIVE16/07/18 download Created with Sketch. 101.52KB
ANP Appendix 3B28/06/18 download Created with Sketch. 685.47KB
ANP 121 Tech Investment Hong Kong Conference Presentation14/06/18 download Created with Sketch. 774.74KB
ANP Change in substantial holding from AEF
01/04/20 download Created with Sketch. 205.38KB
ANP Phase II DMD trial database lock and final results on track
18/03/20 download Created with Sketch. 169KB
ANP ATL1102 Phase II data to be presented at DMD Conference
05/03/20 download Created with Sketch. 189.03KB
ANP Half Yearly Report and Half Year Accounts
28/02/20PRICE SENSITIVE download Created with Sketch. 2.4MB
ANP Appointment of US-based Consultant Medical Director
27/02/20PRICE SENSITIVE download Created with Sketch. 141.79KB
ANP Results in DMD unlock value creation potential of ATL1102
06/02/20PRICE SENSITIVE download Created with Sketch. 109.86KB
ANP Quarterly Update & Appendix 4C
30/01/20PRICE SENSITIVE download Created with Sketch. 261.9KB
ANP ANP Presentation for SACHS 3rd Neuroscience Innovation Forum
13/01/20 download Created with Sketch. 2.44MB
ANP ANP to Present at Neuroscience Innovation Forum in the US
10/01/20 download Created with Sketch. 200.78KB
ANP Antisense Therapeutics Limited - Listed Options raise $5.5M
03/01/20PRICE SENSITIVE download Created with Sketch. 152.36KB
ANP Appendix 3B and 708A notice
03/01/20 download Created with Sketch. 565.3KB
ANP Change of Director's Interest Notice (RM, MD, GM, GP, WG)
24/12/19 download Created with Sketch. 335.74KB
ANP Appendix 3B
23/12/19 download Created with Sketch. 334.26KB
ANP Change in substantial holding
23/12/19 download Created with Sketch. 202.39KB
ANP Change in substantial holding from AEF
20/12/19 download Created with Sketch. 564.91KB
ANP Change of Director's Interest Notice - WG
20/12/19 download Created with Sketch. 237.52KB
ANP Change of Director's Interest Notice - RM
20/12/19 download Created with Sketch. 215.4KB
ANP Appendix 3B
19/12/19 download Created with Sketch. 331.4KB
ANP Change of Director's Interest Notice (RM)
19/12/19 download Created with Sketch. 216.49KB
ANP Change of Director's Interest Notice (MD)
18/12/19 download Created with Sketch. 217.32KB
ANP Change of Director's Interest Notice (GM)
18/12/19 download Created with Sketch. 218.46KB
ANP Appendix 3B
18/12/19 download Created with Sketch. 331KB
ANP Reinstatement to Official Quotation
17/12/19PRICE SENSITIVE download Created with Sketch. 214.01KB
ANP Positive results reaffirm plans to advance ATL1102 to P2b
17/12/19PRICE SENSITIVE download Created with Sketch. 318.57KB
ANP Antisense Therapeutics - Underwriting of Listed Options
17/12/19PRICE SENSITIVE download Created with Sketch. 122.56KB
ANP Change of Director's Interest Notice - RM
16/12/19 download Created with Sketch. 279.65KB
ANP Appendix 3B
16/12/19 download Created with Sketch. 330.53KB
ANP Suspension from Official Quotation
16/12/19PRICE SENSITIVE download Created with Sketch. 433.54KB
ANP Clarification of the Trading Halt
12/12/19 download Created with Sketch. 70.84KB
ANP Trading Halt
12/12/19PRICE SENSITIVE download Created with Sketch. 432.15KB
ANP Results of Meeting
11/12/19 download Created with Sketch. 267.87KB
ANP AGM Presentation 2019
11/12/19PRICE SENSITIVE download Created with Sketch. 2.28MB
ANP Change of Director's Interest Notice - Robert Moses
04/12/19 download Created with Sketch. 269.78KB
ANP Appendix 3B
04/12/19 download Created with Sketch. 257.7KB
ANP Appendix 3B
25/11/19 download Created with Sketch. 301.94KB
ANP Dosing completed in ATL1102 Phase II DMD trial
20/11/19PRICE SENSITIVE download Created with Sketch. 146.68KB
ANP Additional ATL1102 trial data presented at DMD UK conference
18/11/19 download Created with Sketch. 1.86MB
ANP Expiry of Listed Options
15/11/19 download Created with Sketch. 150.38KB
ANP Change in substantial holding from AEF
14/11/19 download Created with Sketch. 83.11KB
ANP Antisense Therapeutics Listed Option ANPOB Exercise
13/11/19 download Created with Sketch. 93.8KB
ANP Appendix 3B
12/11/19 download Created with Sketch. 256.97KB
ANP Notice of Annual General Meeting/Proxy Form
11/11/19 download Created with Sketch. 9.7MB
ANP Change in substantial holding from AEF
06/11/19 download Created with Sketch. 83.09KB
ANP Appendix 4G
31/10/19 download Created with Sketch. 205.43KB
ANP Annual Report
31/10/19 download Created with Sketch. 8.51MB
ANP Appendix 3B
29/10/19 download Created with Sketch. 257.21KB
ANP Neuromuscular Drug Development Summit Poster Presentation
25/10/19 download Created with Sketch. 511.71KB
ANP Appendix 4C - quarterly
25/10/19PRICE SENSITIVE download Created with Sketch. 290.03KB
ANP Techknow Conference Presentation
22/10/19 download Created with Sketch. 2.34MB
ANP ANP to present at Neuromuscular Drug Development Summit USA
17/10/19 download Created with Sketch. 183.52KB
ANP Change in substantial holding
11/10/19 download Created with Sketch. 252.14KB
ANP Change in substantial holding from AEF
09/10/19 download Created with Sketch. 81.87KB
ANP Response to ASX Price Query
07/10/19PRICE SENSITIVE download Created with Sketch. 479.4KB
ANP Appendix 3B
04/10/19 download Created with Sketch. 306.63KB
ANP Positive preliminary results from ATL1102 DMD Phase II trial
18/09/19PRICE SENSITIVE download Created with Sketch. 461.75KB
ANP Trading Halt
17/09/19PRICE SENSITIVE download Created with Sketch. 430.81KB
ANP ATL1102 for DMD European regulatory interactions
02/09/19PRICE SENSITIVE download Created with Sketch. 161.6KB
ANP Appendix 4E and Full Year Statutory Accounts
30/08/19PRICE SENSITIVE download Created with Sketch. 911.49KB
ANP Acromegaly Early Access Program Status Update
26/08/19PRICE SENSITIVE download Created with Sketch. 150.58KB
ANP Change in substantial holding
31/07/19 download Created with Sketch. 260.61KB
ANP Phase II DMD clinical trial on track for dosing completion
24/07/19PRICE SENSITIVE download Created with Sketch. 104.3KB
ANP Appendix 4C - quarterly
18/07/19PRICE SENSITIVE download Created with Sketch. 203.32KB
ANP Conference Presentation
25/06/19 download Created with Sketch. 2.72MB
ANP Updated Investor Presentation
29/05/19 download Created with Sketch. 2.6MB
ANP Phase II clinical trial in DMD Fully Enrolled
24/05/19PRICE SENSITIVE download Created with Sketch. 135.89KB
ANP Employee Share Ownership Plan (ESOP)
26/04/19 download Created with Sketch. 63.51KB
ANP Appendix 4C - quarterly
26/04/19PRICE SENSITIVE download Created with Sketch. 247.86KB
ANP Phase II clinical trial in DMD Update
04/04/19PRICE SENSITIVE download Created with Sketch. 158.07KB
ANP Change in substantial holding
18/03/19 download Created with Sketch. 215.44KB
ANP Change in substantial holding from AEF
18/03/19 download Created with Sketch. 300.87KB
ANP Becoming a substantial holder CityCastle Pty Ltd
15/03/19 download Created with Sketch. 799.76KB
ANP Completion of $1,600,000 Share Placement
15/03/19 download Created with Sketch. 353.7KB
ANP Placement to Accelerate Development of ATL1102 in DMD
13/03/19PRICE SENSITIVE download Created with Sketch. 106.85KB
ANP Trading Halt
11/03/19PRICE SENSITIVE download Created with Sketch. 631.05KB
ANP Pause in trading
11/03/19PRICE SENSITIVE download Created with Sketch. 116.97KB
ANP Half Yearly Report and Accounts
27/02/19PRICE SENSITIVE download Created with Sketch. 563.62KB
ANP Appendix 4C - quarterly
30/01/19PRICE SENSITIVE download Created with Sketch. 204.38KB
ANP Updated Company Presentation
23/01/19 download Created with Sketch. 3.77MB
ANP Phase II clinical trial in DMD Update
18/01/19PRICE SENSITIVE download Created with Sketch. 131.34KB
ANP Receipt of R&D Tax Incentive payment
04/12/18PRICE SENSITIVE download Created with Sketch. 87.74KB
ANP Results of Meeting
29/11/18 download Created with Sketch. 174.94KB
ANP AGM Presentation
29/11/18 download Created with Sketch. 1.6MB
ANP Appendix 4G
09/11/18 download Created with Sketch. 180.06KB
ANP Change of Director's Interest Notice (RM)
02/11/18 download Created with Sketch. 133.82KB
ANP Change of Director's Interest Notice (MD)
02/11/18 download Created with Sketch. 133.63KB
ANP Investor Presentation
30/10/18 download Created with Sketch. 1.68MB
ANP Notice of Annual General Meeting/Proxy Form
29/10/18 download Created with Sketch. 4.2MB
ANP Appendix 4C - quarterly
29/10/18PRICE SENSITIVE download Created with Sketch. 187.13KB
ANP Response to ASX Price and Volume Query
16/10/18PRICE SENSITIVE download Created with Sketch. 164.63KB
ANP Duchenne ACTT Now Conference 2018
06/09/18 download Created with Sketch. 116.61KB
ANP Full Year Statutory Accounts
29/08/18PRICE SENSITIVE download Created with Sketch. 1.04MB
ANP First Patient Dosed in Phase II DMD Clinical Trial
29/08/18PRICE SENSITIVE download Created with Sketch. 121.94KB
ANP Pause in Trading
29/08/18PRICE SENSITIVE download Created with Sketch. 117.63KB
ANP ANP to Present at 14th Annual Bioshares Biotech Summit
27/07/18 download Created with Sketch. 1013.55KB
ANP Change of Director's Interest Notice (RM)
26/07/18 download Created with Sketch. 20.77KB
ANP Appendix 4C - quarterly
24/07/18PRICE SENSITIVE download Created with Sketch. 529.19KB
ANP Company Appointment
23/07/18 download Created with Sketch. 115.02KB
ANP ANP initiates ATL1102 Phase II clinical trial in DMD
16/07/18PRICE SENSITIVE download Created with Sketch. 101.52KB
ANP Appendix 3B
28/06/18 download Created with Sketch. 685.47KB
ANP 121 Tech Investment Hong Kong Conference Presentation
14/06/18 download Created with Sketch. 774.74KB
(20min delay)
Last
4.5¢
Change
-0.003(6.25%)
Mkt cap ! $21.99M
Open High Low Value Volume
4.7¢ 5.0¢ 4.5¢ $34.11K 727.0K

Buyers (Bids)

No. Vol. Price($)
1 32548 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.7¢ 285000 2
View Market Depth
Last trade - 15.46pm 01/04/2020 (20 minute delay) ?
(live)
Last
4.5¢
  Change
-0.003 ( 2.17 %)
Open High Low Volume
4.8¢ 5.0¢ 4.5¢ 64251
Last updated 13.07pm 01/04/2020 (live) ?
ANP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.